Despite a significant net loss, GRAIL Inc (GRAL) reports strong revenue growth and strategic collaborations, setting the stage for future advancements.

The local sector of test makers, specialized equipment manufacturers and testing product suppliers remain invested in their ...

The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.

Discover how Grail Inc. achieved 45% revenue growth, improved scalability with the updated Galleri test, and navigates legislative and market challenges.

USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Feb. 19, 2025 /PRNewswire/ -- USA News Group News Commentary - Amid the excitement surrounding ...

You better check LifeLabs’ website if you have an appointment with the company in the coming days. Workers at LifeLabs, the ...

Last week Pfizer announced that Ian Read is to step down as CEO, with chief operating officer ... Currently chief information officer at Quest Diagnostics, Fonseca will join Pfizer’s executive ...

The Robert De Niro-led Netflix conspiracy thriller has noble ambitions but an unsatisfactory message. Here's what happens in ...

Quest Diagnostics, DaVita ... today announced that Dirk Allison, Chairman and Chief Executive Officer, Brad Bickham, President and Chief Operating Officer, and Brian Poff, Executive Vice President ...

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Interim CEO Brent Shafer said the medical products maker is ready to begin a new era after several years of “heavy lifting” ...